View in EDS HTML Full Text PDF Full Text

DNMT2‐m5C‐ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation‐Mediated Notch Pathway.

Saved in:
Bibliographic Details
Title: DNMT2‐m5C‐ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation‐Mediated Notch Pathway.
Authors: Yang, Shiguang1,2 (AUTHOR), Li, Jie3 (AUTHOR), Mao, Shengwei1 (AUTHOR), Zhao, Xuhui1 (AUTHOR), Liu, Douwaner4 (AUTHOR), Chen, Jiafeng1 (AUTHOR), Fu, Jialu1 (AUTHOR), Bu, Yichao1 (AUTHOR), Wu, Xiaoling1 (AUTHOR), Liu, Shaoqing5 (AUTHOR), Yu, Qifeng6 (AUTHOR), Dong, Qiongzhu2 (AUTHOR) qzhdong@fudan.edu.cn, Tang, Zheng1 (AUTHOR) tang.zheng@zs-hospital.sh.cn, Fang, Yuan1 (AUTHOR) fangyuan1029@126.com, Shi, Yinghong1 (AUTHOR) shi.yinghong@zs-hospital.sh.cn
Source: Advanced Science. 3/3/2026, Vol. 13 Issue 13, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21983844
DOI:10.1002/advs.202515931